Vanderbilt University Medical Center: Long-Term Follow Up Pinpoints Side Effects of Treatments for Prostate Cancer Patients
January 25, 2024
January 25, 2024
NASHVILLE, Tennessee, Jan. 25 (TNSres) -- Vanderbilt University Medical Center issued the following news:
A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.
The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation for Localized Prostate Cancer) study, coordinated by Vanderbilt University Medical Center (VUMC), is a mult . . .
A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.
The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation for Localized Prostate Cancer) study, coordinated by Vanderbilt University Medical Center (VUMC), is a mult . . .